{"gene":"RDH10","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2007,"finding":"RDH10 is a short-chain dehydrogenase/reductase that catalyzes the oxidation of retinol to retinal (first step of retinoic acid synthesis); a point mutation in the trex mouse abolishes this enzymatic activity, leading to insufficient RA signaling and embryonic defects in craniofacial, limb, and organ development.","method":"ENU forward genetic screen, protein modeling, enzymatic assays, mutant embryo analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with mutagenesis validation plus in vivo genetic evidence, highly cited foundational paper","pmids":["17473173"],"is_preprint":false},{"year":2004,"finding":"RDH10 functions as an all-trans retinol dehydrogenase localized to the microsomal (membrane) fraction of retinal Müller cells, using NADP+ as its preferred cofactor to generate all-trans retinal.","method":"Western blot, immunohistochemistry, RT-PCR, HPLC-based enzymatic activity assay on microsomal fractions, cofactor preference determination","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1-2 — direct enzymatic assay with subcellular fractionation and cofactor specificity, multiple orthogonal methods","pmids":["15505029"],"is_preprint":false},{"year":2008,"finding":"Human RDH10 is a strictly NAD+-dependent enzyme (not NADP+-dependent as initially reported) with the lowest apparent Km for all-trans-retinol (~0.035 µM) among NAD+-dependent retinoid oxidoreductases; it also accepts cis-retinols as substrates and functions exclusively in the oxidative direction in cells, increasing retinaldehyde and retinoic acid levels. siRNA-mediated silencing of RDH10 in human cells significantly decreases RA production from retinol.","method":"Kinetic enzyme assays, siRNA knockdown, retinoid quantification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — rigorous in vitro kinetic characterization combined with cell-based siRNA knockdown and product quantification","pmids":["18502750"],"is_preprint":false},{"year":2009,"finding":"RDH10 oxidizes 11-cis-retinol to 11-cis-retinaldehyde in vitro (enhanced by CRALBP); physically interacts with CRALBP and RPE65 as shown by co-immunoprecipitation; co-localizes with RPE65 and CRALBP in bovine RPE cells; and can reconstitute the visual cycle chromophore 11-cis-retinaldehyde from all-trans-retinol when co-expressed with RPE65, LRAT, and CRALBP.","method":"In vitro enzymatic assay, reconstitution in HEK-293A cells, co-immunoprecipitation, immunocytochemistry, HPLC retinoid profiling","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of visual cycle, direct protein-protein interaction by co-IP, and in vitro enzymatic assay with multiple orthogonal methods","pmids":["19458327"],"is_preprint":false},{"year":2011,"finding":"RDH10 is the primary retinol dehydrogenase responsible for the first step of embryonic vitamin A oxidation; this step occurs predominantly in a membrane-bound cellular compartment, which prevents inhibition by cytosolic CRBP1 (RBP1), and widely-expressed cytosolic RDH enzymes play only a minor role under normal dietary conditions.","method":"Rdh10(trex) mutant embryos, dietary retinaldehyde supplementation rescue experiments, RDH activity assays, subcellular fractionation","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 — genetic rescue combined with enzymatic activity assays and subcellular fractionation, multiple orthogonal approaches","pmids":["21782811"],"is_preprint":false},{"year":2011,"finding":"RDH10 is required for interdigital RA signaling and subsequent interdigital tissue loss, but is not required for limb patterning (Meis2/Shh expression and skeletal patterning remain normal in Rdh10 mutants); RA activity in Rdh10 mutants is detected in neuroectoderm but not limbs during initiation and patterning.","method":"Rdh10(trex/trex) mutant analysis, RARE-lacZ RA reporter transgene, RA rescue treatment, in situ hybridization, skeletal staining","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis using reporter transgene with RA rescue validation and specific phenotypic readouts","pmids":["21360789"],"is_preprint":false},{"year":2012,"finding":"Rdh10 associates predominantly with mitochondria/mitochondrial-associated membrane (MAM) in the absence of lipid droplet biosynthesis, but redistributes to lipid droplets during acyl ester biosynthesis; the 32 N-terminal residues (hydrophobic region plus net positive charge) are required for lipid droplet targeting, while both N-terminal and 48 C-terminal hydrophobic residues are required for mitochondria/MAM targeting and protein stability.","method":"Subcellular fractionation, live-cell imaging/colocalization, domain deletion analysis, colocalization with CRBP1 and LRAT","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiments with domain mutagenesis defining specific targeting sequences and functional consequence","pmids":["23155051"],"is_preprint":false},{"year":2013,"finding":"RDH10 is a required component of a PPARγ-directed linear pathway for ATRA synthesis in human dendritic cells, acting upstream of RALDH2 and CRABP2; all three proteins are regulated by PPARγ and are necessary for ATRA production induced by PPARγ activation.","method":"siRNA knockdown, ATRA quantification, PPARγ agonist treatment, expression analysis in human mo-DCs and murine DC subsets","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional pathway placement by knockdown with product quantification, single lab","pmids":["23833249"],"is_preprint":false},{"year":2018,"finding":"Rdh10 catalyzes the first step of atRA biosynthesis postnatally; embryonic fibroblasts with Rdh10 knockout show decreased atRA biosynthesis and increased adipogenesis, reversed by atRA or RAR pan-agonist treatment; Rdh10 heterozygote mice show modestly reduced tissue atRA with increased adiposity and metabolic defects, establishing RDH10 as physiologically essential for atRA-mediated metabolic control.","method":"Rdh10 heterozygote and knockout mouse models, atRA quantification by LC-MS, adipogenesis assays, in vivo metabolic phenotyping, pharmacological rescue with atRA","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with direct metabolite quantification and pharmacological rescue, multiple phenotypic readouts","pmids":["29321172"],"is_preprint":false},{"year":2017,"finding":"RDH10 is specifically required in non-neural crest cells prior to E10.5 for proper choanae formation; loss of Rdh10 leads to ectopic Fgf8 expression in the nasal fin, decreased cell proliferation and increased cell death in nasal cavity epithelium, causing choanal atresia.","method":"Conditional/tissue-specific Rdh10 mutant mouse analysis, in situ hybridization for Fgf8, cell proliferation and apoptosis assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific genetic loss-of-function with defined molecular (Fgf8 misexpression) and cellular (proliferation/death) readouts","pmids":["28169399"],"is_preprint":false},{"year":2018,"finding":"RDH10-mediated retinoic acid signaling is required for submandibular salivary gland initiation; RA signaling acts through RARα specifically (not other RAR isoforms); Rdh10 and Aldh1a2 are co-expressed in SMG mesenchyme at the site of gland initiation.","method":"Ex vivo SMG initiation assay, Rdh10 conditional loss-of-function, RAR isoform-specific pharmacological analysis, expression localization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with isoform-specific receptor dissection in a novel ex vivo functional assay","pmids":["29986869"],"is_preprint":false},{"year":2019,"finding":"RDH10-mediated retinoic acid signaling is required for spontaneous fetal mouth movement; Rdh10-deficient embryos display mispatterned pharyngeal nerves and skeletal elements that block fetal mouth movement in utero, leading to cleft palate via a biomechanical mechanism.","method":"Stage-specific Rdh10 inactivation, X-ray microtomography, in utero ultrasound video, ex vivo culture, tissue staining","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with direct in utero biomechanical readout using multiple imaging modalities","pmids":["31300413"],"is_preprint":false},{"year":2025,"finding":"Rdh10-mediated RA signaling is required for vagal neural crest cell (NCC) invasion into the foregut to form the enteric nervous system; Rdh10 loss-of-function causes intestinal aganglionosis; Rdh10 expression in mesenchyme surrounding the foregut entrance is essential between E7.5-E9.5; RNA-seq revealed downregulation of the Ret-Gdnf-Gfrα1 signaling network and altered extracellular matrix (increased collagen deposition) in Rdh10 mutants, restricting NCC entry.","method":"Rdh10 loss-of-function mouse embryos, comparative RNA-seq, NCC lineage tracing, collagen staining","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with transcriptomic pathway analysis and ECM characterization, preprint not yet peer-reviewed","pmids":["39896510"],"is_preprint":true},{"year":2025,"finding":"Rdh10-derived RA directly activates Alx1 transcription via an RA response element (RARE) near the Alx1 locus, as demonstrated by decreased H3K27ac at the Alx1 locus and decreased Alx1 expression in Rdh10-/- eye tissue; Alx1 knockout recapitulates the optic cup formation defect seen in Rdh10 knockouts, placing Alx1 as a direct downstream RA target gene in eye development.","method":"ChIP-seq (H3K27ac), RNA-seq on Rdh10-/- eye tissue, RARE identification, in situ hybridization, CRISPR/Cas9 Alx1 knockout","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq with RARE identification and genetic epistasis via CRISPR KO, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.06.24.661406"],"is_preprint":true}],"current_model":"RDH10 is a membrane-associated, NAD+-dependent short-chain dehydrogenase/reductase that catalyzes the rate-limiting first oxidative step of retinoic acid biosynthesis — conversion of retinol to retinaldehyde — in a membrane-bound compartment (mitochondria/MAM and lipid droplets) that shields it from cytosolic CRBP1 inhibition; it physically interacts with RPE65 and CRALBP in the visual cycle, and its spatiotemporally regulated enzymatic activity in mesenchymal tissues is essential for local RA production that controls craniofacial morphogenesis, limb interdigitation, ENS formation, salivary gland initiation, and multiple other developmental processes through downstream RAR-mediated transcriptional programs."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing that RDH10 possesses retinol dehydrogenase activity and is membrane-associated answered the basic question of its enzymatic identity and subcellular context, initially placing it as a microsomal NADP⁺-dependent enzyme in retinal Müller cells.","evidence":"Western blot, immunohistochemistry, HPLC-based enzymatic assay on microsomal fractions of bovine retinal cells","pmids":["15505029"],"confidence":"High","gaps":["Cofactor preference was later revised","Activity was measured only in retinal cells, not embryonic tissues","No in vivo loss-of-function data"]},{"year":2007,"claim":"Forward genetic identification of the trex mouse mutation in Rdh10 established it as the principal retinol dehydrogenase for embryonic RA synthesis, linking its catalytic activity to craniofacial, limb, and organ development in vivo.","evidence":"ENU mutagenesis screen in mice, enzymatic assays, mutant embryo phenotyping","pmids":["17473173"],"confidence":"High","gaps":["Tissue-specific requirements were undefined","Whether other RDHs compensate partially was unclear","Downstream transcriptional targets not identified"]},{"year":2008,"claim":"Rigorous kinetic characterization corrected the cofactor specificity to NAD⁺ (not NADP⁺), revealed an exceptionally low Km for retinol, and demonstrated through siRNA knockdown that RDH10 is required for RA production in human cells, establishing its biochemical parameters.","evidence":"Kinetic enzyme assays with purified protein, siRNA knockdown in human cells, retinoid quantification","pmids":["18502750"],"confidence":"High","gaps":["Structural basis for NAD⁺ selectivity unknown","Regulation of enzyme turnover not addressed"]},{"year":2009,"claim":"Demonstrating that RDH10 oxidizes 11-cis-retinol, physically interacts with RPE65 and CRALBP, and reconstitutes chromophore production when co-expressed with visual cycle components placed RDH10 within the retinal visual cycle.","evidence":"Co-immunoprecipitation, reconstitution assay in HEK-293A cells co-expressing RPE65/LRAT/CRALBP, HPLC retinoid profiling","pmids":["19458327"],"confidence":"High","gaps":["In vivo contribution to visual cycle chromophore regeneration not tested","Structural basis of RPE65/CRALBP interaction not resolved","Relative contribution versus RDH5 or RDH11 in RPE unclear"]},{"year":2011,"claim":"Demonstrating that RDH10 operates in a membrane-bound compartment insulated from cytosolic CRBP1 inhibition, and that cytosolic RDH enzymes play only minor roles, resolved why membrane localization is functionally critical for embryonic RA synthesis.","evidence":"Rdh10(trex) mutant embryos, dietary retinaldehyde rescue, subcellular fractionation, RDH activity assays","pmids":["21782811"],"confidence":"High","gaps":["Identity of the specific membrane compartment was not yet defined","How retinol accesses the membrane-bound enzyme from holo-RBP delivery was unresolved"]},{"year":2011,"claim":"Genetic analysis showed RDH10 is required for interdigital RA signaling and tissue regression but dispensable for limb patterning (Shh/Meis2), demonstrating tissue-specific selectivity of its developmental requirement.","evidence":"Rdh10(trex/trex) mutant limb analysis with RARE-lacZ reporter, RA rescue, skeletal staining","pmids":["21360789"],"confidence":"High","gaps":["Direct RA targets mediating interdigital apoptosis not identified","Whether other RA sources supply the proximal limb was unresolved"]},{"year":2012,"claim":"Defining RDH10's dual localization to mitochondria/MAM and lipid droplets, governed by distinct N-terminal and C-terminal hydrophobic domains, resolved the membrane identity question and explained compartmentalized retinoid metabolism.","evidence":"Live-cell imaging, subcellular fractionation, domain deletion constructs, colocalization studies","pmids":["23155051"],"confidence":"High","gaps":["How lipid droplet targeting affects catalytic output in vivo was not tested","No crystal structure to map targeting domains"]},{"year":2013,"claim":"Placing RDH10 in a PPARγ-regulated linear RA biosynthesis pathway in dendritic cells (upstream of RALDH2 and CRABP2) extended its functional role beyond embryogenesis into immune cell biology.","evidence":"siRNA knockdown in human monocyte-derived dendritic cells, PPARγ agonist treatment, ATRA quantification","pmids":["23833249"],"confidence":"Medium","gaps":["Single lab finding in one immune cell type","In vivo immune phenotype of Rdh10 loss in DCs not examined","Whether PPARγ regulation of RDH10 is conserved across tissues is unknown"]},{"year":2017,"claim":"Tissue-specific conditional knockout revealed that RDH10 in non-neural crest cells is required before E10.5 for choanae formation, acting through regulation of Fgf8 expression and control of nasal epithelial proliferation and survival.","evidence":"Conditional Rdh10 mutant mice, Fgf8 in situ hybridization, cell proliferation and apoptosis assays","pmids":["28169399"],"confidence":"High","gaps":["Whether Fgf8 is a direct or indirect RA target was not determined","Specific RAR isoform involved was not tested"]},{"year":2018,"claim":"Heterozygous Rdh10 mice display reduced tissue RA, increased adiposity, and metabolic defects rescued by RA supplementation, establishing that RDH10-dependent RA synthesis is haploinsufficient for postnatal metabolic homeostasis.","evidence":"Rdh10 heterozygote and knockout mouse models, LC-MS RA quantification, adipogenesis assays, pharmacological rescue","pmids":["29321172"],"confidence":"High","gaps":["Tissue-specific metabolic requirements not dissected with conditional models","Downstream RAR target genes in adipose tissue not identified"]},{"year":2018,"claim":"RDH10-derived RA acts specifically through RARα to initiate submandibular salivary gland formation, with Rdh10 and Aldh1a2 co-expressed in the initiating mesenchyme, demonstrating RAR isoform specificity downstream of RDH10.","evidence":"Rdh10 conditional loss-of-function, ex vivo SMG initiation assay, RAR isoform-specific agonists/antagonists","pmids":["29986869"],"confidence":"High","gaps":["Direct RA target genes in salivary gland mesenchyme not identified","Whether other RDHs partially compensate in this tissue is unknown"]},{"year":2019,"claim":"Revealing that Rdh10 loss causes mispatterned pharyngeal nerves and skeletal elements that physically block fetal mouth movement, leading to cleft palate, established a novel biomechanical mechanism downstream of RA signaling.","evidence":"Stage-specific Rdh10 inactivation, in utero ultrasound, X-ray microtomography, ex vivo culture","pmids":["31300413"],"confidence":"High","gaps":["Which RA target genes control pharyngeal nerve patterning is unknown","Whether the biomechanical mechanism accounts for all RA-deficiency cleft palate cases is untested"]},{"year":null,"claim":"Key unresolved questions include the atomic structure of RDH10, the full repertoire of direct RA-responsive target genes mediating its diverse developmental functions, the relative contribution of RDH10 versus other RDHs in adult tissues, and whether RDH10 mutations cause human Mendelian disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure available","Systematic identification of direct downstream RA target genes across tissues is lacking","Human genetic disease association through causative mutations not established in primary literature"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,3]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[6]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,4,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,5,9,10,11]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[1,3]}],"complexes":[],"partners":["RPE65","CRALBP","CRBP1","ALDH1A2","CRABP2","LRAT"],"other_free_text":[]},"mechanistic_narrative":"RDH10 is a membrane-associated, NAD⁺-dependent short-chain dehydrogenase/reductase that catalyzes the rate-limiting first oxidative step in retinoic acid (RA) biosynthesis—the conversion of all-trans-retinol to all-trans-retinal—with the lowest known Km (~0.035 µM) among NAD⁺-dependent retinoid oxidoreductases [PMID:18502750]. The enzyme resides at mitochondria-associated membranes and lipid droplets, where its membrane compartmentalization shields it from inhibition by cytosolic CRBP1; N-terminal and C-terminal hydrophobic domains govern its dual targeting [PMID:23155051, PMID:21782811]. In the visual cycle, RDH10 also oxidizes 11-cis-retinol to 11-cis-retinal and physically interacts with RPE65 and CRALBP to reconstitute chromophore production [PMID:19458327]. Spatiotemporally regulated RDH10 activity in mesenchymal tissues is essential for local RA production that controls craniofacial morphogenesis, limb interdigital apoptosis, choanae formation, salivary gland initiation, fetal mouth movement, enteric nervous system development, and postnatal metabolic homeostasis through downstream RAR-mediated transcription [PMID:17473173, PMID:21360789, PMID:28169399, PMID:29986869, PMID:31300413, PMID:29321172]."},"prefetch_data":{"uniprot":{"accession":"Q8IZV5","full_name":"Retinol dehydrogenase 10","aliases":["Short chain dehydrogenase/reductase family 16C member 4"],"length_aa":341,"mass_kda":38.1,"function":"Retinol dehydrogenase with a clear preference for NADP. Converts all-trans-retinol to all-trans-retinal. Has no detectable activity towards 11-cis-retinol, 9-cis-retinol and 13-cis-retinol","subcellular_location":"Microsome membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q8IZV5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RDH10","classification":"Not Classified","n_dependent_lines":41,"n_total_lines":1208,"dependency_fraction":0.03394039735099338},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RDH10","total_profiled":1310},"omim":[{"mim_id":"607599","title":"RETINOL DEHYDROGENASE 10; RDH10","url":"https://www.omim.org/entry/607599"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Lipid droplets","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RDH10"},"hgnc":{"alias_symbol":["SDR16C4"],"prev_symbol":[]},"alphafold":{"accession":"Q8IZV5","domains":[{"cath_id":"3.40.50.720","chopping":"32-338","consensus_level":"high","plddt":91.8278,"start":32,"end":338}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IZV5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IZV5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IZV5-F1-predicted_aligned_error_v6.png","plddt_mean":91.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RDH10","jax_strain_url":"https://www.jax.org/strain/search?query=RDH10"},"sequence":{"accession":"Q8IZV5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IZV5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IZV5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IZV5"}},"corpus_meta":[{"pmid":"17473173","id":"PMC_17473173","title":"RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17473173","citation_count":272,"is_preprint":false},{"pmid":"21782811","id":"PMC_21782811","title":"RDH10 is the primary enzyme responsible for the first step of embryonic Vitamin A metabolism and retinoic acid synthesis.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21782811","citation_count":63,"is_preprint":false},{"pmid":"15505029","id":"PMC_15505029","title":"Identification of RDH10, an All-trans Retinol Dehydrogenase, in Retinal Muller Cells.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15505029","citation_count":60,"is_preprint":false},{"pmid":"18502750","id":"PMC_18502750","title":"Kinetic analysis of human enzyme RDH10 defines the characteristics of a physiologically relevant retinol dehydrogenase.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18502750","citation_count":57,"is_preprint":false},{"pmid":"19458327","id":"PMC_19458327","title":"The 11-cis-retinol dehydrogenase activity of RDH10 and its interaction with visual cycle proteins.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19458327","citation_count":57,"is_preprint":false},{"pmid":"21360789","id":"PMC_21360789","title":"Rdh10 mutants deficient in limb field retinoic acid signaling exhibit normal limb patterning but display interdigital webbing.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21360789","citation_count":53,"is_preprint":false},{"pmid":"17849458","id":"PMC_17849458","title":"Expression of the murine retinol dehydrogenase 10 (Rdh10) gene correlates with many sites of retinoid signalling during embryogenesis and organ differentiation.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17849458","citation_count":48,"is_preprint":false},{"pmid":"29321172","id":"PMC_29321172","title":"Modest Decreases in Endogenous All-trans-Retinoic Acid Produced by a Mouse Rdh10 Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29321172","citation_count":42,"is_preprint":false},{"pmid":"23155051","id":"PMC_23155051","title":"The retinol dehydrogenase Rdh10 localizes to lipid droplets during acyl ester biosynthesis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23155051","citation_count":41,"is_preprint":false},{"pmid":"22162152","id":"PMC_22162152","title":"Morphological defects in a novel Rdh10 mutant that has reduced retinoic acid biosynthesis and signaling.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/22162152","citation_count":36,"is_preprint":false},{"pmid":"18399539","id":"PMC_18399539","title":"Dynamic expression of the retinoic acid-synthesizing enzyme retinol dehydrogenase 10 (rdh10) in the developing mouse brain and sensory organs.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18399539","citation_count":32,"is_preprint":false},{"pmid":"28169399","id":"PMC_28169399","title":"Rdh10 loss-of-function and perturbed retinoid signaling underlies the etiology of choanal atresia.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28169399","citation_count":25,"is_preprint":false},{"pmid":"23833249","id":"PMC_23833249","title":"RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.","date":"2013","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/23833249","citation_count":24,"is_preprint":false},{"pmid":"20563989","id":"PMC_20563989","title":"The expression of Stra6 and Rdh10 in the avian embryo and their contribution to the generation of retinoid signatures.","date":"2010","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20563989","citation_count":20,"is_preprint":false},{"pmid":"29986869","id":"PMC_29986869","title":"RDH10-mediated retinol metabolism and RARα-mediated retinoic acid signaling are required for submandibular salivary gland initiation.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29986869","citation_count":19,"is_preprint":false},{"pmid":"17218779","id":"PMC_17218779","title":"Forced expression of RDH10 gene retards growth of HepG2 cells.","date":"2007","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/17218779","citation_count":15,"is_preprint":false},{"pmid":"31300413","id":"PMC_31300413","title":"RDH10 function is necessary for spontaneous fetal mouth movement that facilitates palate shelf elevation.","date":"2019","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31300413","citation_count":14,"is_preprint":false},{"pmid":"14596915","id":"PMC_14596915","title":"Genomic organization and transcription of the human retinol dehydrogenase 10 (RDH10) gene.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/14596915","citation_count":9,"is_preprint":false},{"pmid":"39896510","id":"PMC_39896510","title":"Rdh10-mediated Retinoic Acid Signaling Regulates the Neural Crest Cell Microenvironment During ENS Formation.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39896510","citation_count":2,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.24.661406","title":"Retinoic acid-regulated epigenetic marks identify <i>Alx1</i> as a direct target gene required for optic cup formation","date":"2025-06-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.24.661406","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10968,"output_tokens":3582,"usd":0.043317},"stage2":{"model":"claude-opus-4-6","input_tokens":7004,"output_tokens":3038,"usd":0.166455},"total_usd":0.209772,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"RDH10 is a short-chain dehydrogenase/reductase that catalyzes the oxidation of retinol to retinal (first step of retinoic acid synthesis); a point mutation in the trex mouse abolishes this enzymatic activity, leading to insufficient RA signaling and embryonic defects in craniofacial, limb, and organ development.\",\n      \"method\": \"ENU forward genetic screen, protein modeling, enzymatic assays, mutant embryo analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with mutagenesis validation plus in vivo genetic evidence, highly cited foundational paper\",\n      \"pmids\": [\"17473173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RDH10 functions as an all-trans retinol dehydrogenase localized to the microsomal (membrane) fraction of retinal Müller cells, using NADP+ as its preferred cofactor to generate all-trans retinal.\",\n      \"method\": \"Western blot, immunohistochemistry, RT-PCR, HPLC-based enzymatic activity assay on microsomal fractions, cofactor preference determination\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct enzymatic assay with subcellular fractionation and cofactor specificity, multiple orthogonal methods\",\n      \"pmids\": [\"15505029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Human RDH10 is a strictly NAD+-dependent enzyme (not NADP+-dependent as initially reported) with the lowest apparent Km for all-trans-retinol (~0.035 µM) among NAD+-dependent retinoid oxidoreductases; it also accepts cis-retinols as substrates and functions exclusively in the oxidative direction in cells, increasing retinaldehyde and retinoic acid levels. siRNA-mediated silencing of RDH10 in human cells significantly decreases RA production from retinol.\",\n      \"method\": \"Kinetic enzyme assays, siRNA knockdown, retinoid quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous in vitro kinetic characterization combined with cell-based siRNA knockdown and product quantification\",\n      \"pmids\": [\"18502750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RDH10 oxidizes 11-cis-retinol to 11-cis-retinaldehyde in vitro (enhanced by CRALBP); physically interacts with CRALBP and RPE65 as shown by co-immunoprecipitation; co-localizes with RPE65 and CRALBP in bovine RPE cells; and can reconstitute the visual cycle chromophore 11-cis-retinaldehyde from all-trans-retinol when co-expressed with RPE65, LRAT, and CRALBP.\",\n      \"method\": \"In vitro enzymatic assay, reconstitution in HEK-293A cells, co-immunoprecipitation, immunocytochemistry, HPLC retinoid profiling\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of visual cycle, direct protein-protein interaction by co-IP, and in vitro enzymatic assay with multiple orthogonal methods\",\n      \"pmids\": [\"19458327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RDH10 is the primary retinol dehydrogenase responsible for the first step of embryonic vitamin A oxidation; this step occurs predominantly in a membrane-bound cellular compartment, which prevents inhibition by cytosolic CRBP1 (RBP1), and widely-expressed cytosolic RDH enzymes play only a minor role under normal dietary conditions.\",\n      \"method\": \"Rdh10(trex) mutant embryos, dietary retinaldehyde supplementation rescue experiments, RDH activity assays, subcellular fractionation\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic rescue combined with enzymatic activity assays and subcellular fractionation, multiple orthogonal approaches\",\n      \"pmids\": [\"21782811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RDH10 is required for interdigital RA signaling and subsequent interdigital tissue loss, but is not required for limb patterning (Meis2/Shh expression and skeletal patterning remain normal in Rdh10 mutants); RA activity in Rdh10 mutants is detected in neuroectoderm but not limbs during initiation and patterning.\",\n      \"method\": \"Rdh10(trex/trex) mutant analysis, RARE-lacZ RA reporter transgene, RA rescue treatment, in situ hybridization, skeletal staining\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis using reporter transgene with RA rescue validation and specific phenotypic readouts\",\n      \"pmids\": [\"21360789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rdh10 associates predominantly with mitochondria/mitochondrial-associated membrane (MAM) in the absence of lipid droplet biosynthesis, but redistributes to lipid droplets during acyl ester biosynthesis; the 32 N-terminal residues (hydrophobic region plus net positive charge) are required for lipid droplet targeting, while both N-terminal and 48 C-terminal hydrophobic residues are required for mitochondria/MAM targeting and protein stability.\",\n      \"method\": \"Subcellular fractionation, live-cell imaging/colocalization, domain deletion analysis, colocalization with CRBP1 and LRAT\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with domain mutagenesis defining specific targeting sequences and functional consequence\",\n      \"pmids\": [\"23155051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RDH10 is a required component of a PPARγ-directed linear pathway for ATRA synthesis in human dendritic cells, acting upstream of RALDH2 and CRABP2; all three proteins are regulated by PPARγ and are necessary for ATRA production induced by PPARγ activation.\",\n      \"method\": \"siRNA knockdown, ATRA quantification, PPARγ agonist treatment, expression analysis in human mo-DCs and murine DC subsets\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional pathway placement by knockdown with product quantification, single lab\",\n      \"pmids\": [\"23833249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Rdh10 catalyzes the first step of atRA biosynthesis postnatally; embryonic fibroblasts with Rdh10 knockout show decreased atRA biosynthesis and increased adipogenesis, reversed by atRA or RAR pan-agonist treatment; Rdh10 heterozygote mice show modestly reduced tissue atRA with increased adiposity and metabolic defects, establishing RDH10 as physiologically essential for atRA-mediated metabolic control.\",\n      \"method\": \"Rdh10 heterozygote and knockout mouse models, atRA quantification by LC-MS, adipogenesis assays, in vivo metabolic phenotyping, pharmacological rescue with atRA\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with direct metabolite quantification and pharmacological rescue, multiple phenotypic readouts\",\n      \"pmids\": [\"29321172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RDH10 is specifically required in non-neural crest cells prior to E10.5 for proper choanae formation; loss of Rdh10 leads to ectopic Fgf8 expression in the nasal fin, decreased cell proliferation and increased cell death in nasal cavity epithelium, causing choanal atresia.\",\n      \"method\": \"Conditional/tissue-specific Rdh10 mutant mouse analysis, in situ hybridization for Fgf8, cell proliferation and apoptosis assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetic loss-of-function with defined molecular (Fgf8 misexpression) and cellular (proliferation/death) readouts\",\n      \"pmids\": [\"28169399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RDH10-mediated retinoic acid signaling is required for submandibular salivary gland initiation; RA signaling acts through RARα specifically (not other RAR isoforms); Rdh10 and Aldh1a2 are co-expressed in SMG mesenchyme at the site of gland initiation.\",\n      \"method\": \"Ex vivo SMG initiation assay, Rdh10 conditional loss-of-function, RAR isoform-specific pharmacological analysis, expression localization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with isoform-specific receptor dissection in a novel ex vivo functional assay\",\n      \"pmids\": [\"29986869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RDH10-mediated retinoic acid signaling is required for spontaneous fetal mouth movement; Rdh10-deficient embryos display mispatterned pharyngeal nerves and skeletal elements that block fetal mouth movement in utero, leading to cleft palate via a biomechanical mechanism.\",\n      \"method\": \"Stage-specific Rdh10 inactivation, X-ray microtomography, in utero ultrasound video, ex vivo culture, tissue staining\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with direct in utero biomechanical readout using multiple imaging modalities\",\n      \"pmids\": [\"31300413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Rdh10-mediated RA signaling is required for vagal neural crest cell (NCC) invasion into the foregut to form the enteric nervous system; Rdh10 loss-of-function causes intestinal aganglionosis; Rdh10 expression in mesenchyme surrounding the foregut entrance is essential between E7.5-E9.5; RNA-seq revealed downregulation of the Ret-Gdnf-Gfrα1 signaling network and altered extracellular matrix (increased collagen deposition) in Rdh10 mutants, restricting NCC entry.\",\n      \"method\": \"Rdh10 loss-of-function mouse embryos, comparative RNA-seq, NCC lineage tracing, collagen staining\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with transcriptomic pathway analysis and ECM characterization, preprint not yet peer-reviewed\",\n      \"pmids\": [\"39896510\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Rdh10-derived RA directly activates Alx1 transcription via an RA response element (RARE) near the Alx1 locus, as demonstrated by decreased H3K27ac at the Alx1 locus and decreased Alx1 expression in Rdh10-/- eye tissue; Alx1 knockout recapitulates the optic cup formation defect seen in Rdh10 knockouts, placing Alx1 as a direct downstream RA target gene in eye development.\",\n      \"method\": \"ChIP-seq (H3K27ac), RNA-seq on Rdh10-/- eye tissue, RARE identification, in situ hybridization, CRISPR/Cas9 Alx1 knockout\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with RARE identification and genetic epistasis via CRISPR KO, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.06.24.661406\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"RDH10 is a membrane-associated, NAD+-dependent short-chain dehydrogenase/reductase that catalyzes the rate-limiting first oxidative step of retinoic acid biosynthesis — conversion of retinol to retinaldehyde — in a membrane-bound compartment (mitochondria/MAM and lipid droplets) that shields it from cytosolic CRBP1 inhibition; it physically interacts with RPE65 and CRALBP in the visual cycle, and its spatiotemporally regulated enzymatic activity in mesenchymal tissues is essential for local RA production that controls craniofacial morphogenesis, limb interdigitation, ENS formation, salivary gland initiation, and multiple other developmental processes through downstream RAR-mediated transcriptional programs.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RDH10 is a membrane-associated, NAD⁺-dependent short-chain dehydrogenase/reductase that catalyzes the rate-limiting first oxidative step in retinoic acid (RA) biosynthesis—the conversion of all-trans-retinol to all-trans-retinal—with the lowest known Km (~0.035 µM) among NAD⁺-dependent retinoid oxidoreductases [PMID:18502750]. The enzyme resides at mitochondria-associated membranes and lipid droplets, where its membrane compartmentalization shields it from inhibition by cytosolic CRBP1; N-terminal and C-terminal hydrophobic domains govern its dual targeting [PMID:23155051, PMID:21782811]. In the visual cycle, RDH10 also oxidizes 11-cis-retinol to 11-cis-retinal and physically interacts with RPE65 and CRALBP to reconstitute chromophore production [PMID:19458327]. Spatiotemporally regulated RDH10 activity in mesenchymal tissues is essential for local RA production that controls craniofacial morphogenesis, limb interdigital apoptosis, choanae formation, salivary gland initiation, fetal mouth movement, enteric nervous system development, and postnatal metabolic homeostasis through downstream RAR-mediated transcription [PMID:17473173, PMID:21360789, PMID:28169399, PMID:29986869, PMID:31300413, PMID:29321172].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that RDH10 possesses retinol dehydrogenase activity and is membrane-associated answered the basic question of its enzymatic identity and subcellular context, initially placing it as a microsomal NADP⁺-dependent enzyme in retinal Müller cells.\",\n      \"evidence\": \"Western blot, immunohistochemistry, HPLC-based enzymatic assay on microsomal fractions of bovine retinal cells\",\n      \"pmids\": [\"15505029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactor preference was later revised\", \"Activity was measured only in retinal cells, not embryonic tissues\", \"No in vivo loss-of-function data\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Forward genetic identification of the trex mouse mutation in Rdh10 established it as the principal retinol dehydrogenase for embryonic RA synthesis, linking its catalytic activity to craniofacial, limb, and organ development in vivo.\",\n      \"evidence\": \"ENU mutagenesis screen in mice, enzymatic assays, mutant embryo phenotyping\",\n      \"pmids\": [\"17473173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific requirements were undefined\", \"Whether other RDHs compensate partially was unclear\", \"Downstream transcriptional targets not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Rigorous kinetic characterization corrected the cofactor specificity to NAD⁺ (not NADP⁺), revealed an exceptionally low Km for retinol, and demonstrated through siRNA knockdown that RDH10 is required for RA production in human cells, establishing its biochemical parameters.\",\n      \"evidence\": \"Kinetic enzyme assays with purified protein, siRNA knockdown in human cells, retinoid quantification\",\n      \"pmids\": [\"18502750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for NAD⁺ selectivity unknown\", \"Regulation of enzyme turnover not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that RDH10 oxidizes 11-cis-retinol, physically interacts with RPE65 and CRALBP, and reconstitutes chromophore production when co-expressed with visual cycle components placed RDH10 within the retinal visual cycle.\",\n      \"evidence\": \"Co-immunoprecipitation, reconstitution assay in HEK-293A cells co-expressing RPE65/LRAT/CRALBP, HPLC retinoid profiling\",\n      \"pmids\": [\"19458327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution to visual cycle chromophore regeneration not tested\", \"Structural basis of RPE65/CRALBP interaction not resolved\", \"Relative contribution versus RDH5 or RDH11 in RPE unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that RDH10 operates in a membrane-bound compartment insulated from cytosolic CRBP1 inhibition, and that cytosolic RDH enzymes play only minor roles, resolved why membrane localization is functionally critical for embryonic RA synthesis.\",\n      \"evidence\": \"Rdh10(trex) mutant embryos, dietary retinaldehyde rescue, subcellular fractionation, RDH activity assays\",\n      \"pmids\": [\"21782811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific membrane compartment was not yet defined\", \"How retinol accesses the membrane-bound enzyme from holo-RBP delivery was unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic analysis showed RDH10 is required for interdigital RA signaling and tissue regression but dispensable for limb patterning (Shh/Meis2), demonstrating tissue-specific selectivity of its developmental requirement.\",\n      \"evidence\": \"Rdh10(trex/trex) mutant limb analysis with RARE-lacZ reporter, RA rescue, skeletal staining\",\n      \"pmids\": [\"21360789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RA targets mediating interdigital apoptosis not identified\", \"Whether other RA sources supply the proximal limb was unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defining RDH10's dual localization to mitochondria/MAM and lipid droplets, governed by distinct N-terminal and C-terminal hydrophobic domains, resolved the membrane identity question and explained compartmentalized retinoid metabolism.\",\n      \"evidence\": \"Live-cell imaging, subcellular fractionation, domain deletion constructs, colocalization studies\",\n      \"pmids\": [\"23155051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How lipid droplet targeting affects catalytic output in vivo was not tested\", \"No crystal structure to map targeting domains\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placing RDH10 in a PPARγ-regulated linear RA biosynthesis pathway in dendritic cells (upstream of RALDH2 and CRABP2) extended its functional role beyond embryogenesis into immune cell biology.\",\n      \"evidence\": \"siRNA knockdown in human monocyte-derived dendritic cells, PPARγ agonist treatment, ATRA quantification\",\n      \"pmids\": [\"23833249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab finding in one immune cell type\", \"In vivo immune phenotype of Rdh10 loss in DCs not examined\", \"Whether PPARγ regulation of RDH10 is conserved across tissues is unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Tissue-specific conditional knockout revealed that RDH10 in non-neural crest cells is required before E10.5 for choanae formation, acting through regulation of Fgf8 expression and control of nasal epithelial proliferation and survival.\",\n      \"evidence\": \"Conditional Rdh10 mutant mice, Fgf8 in situ hybridization, cell proliferation and apoptosis assays\",\n      \"pmids\": [\"28169399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Fgf8 is a direct or indirect RA target was not determined\", \"Specific RAR isoform involved was not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Heterozygous Rdh10 mice display reduced tissue RA, increased adiposity, and metabolic defects rescued by RA supplementation, establishing that RDH10-dependent RA synthesis is haploinsufficient for postnatal metabolic homeostasis.\",\n      \"evidence\": \"Rdh10 heterozygote and knockout mouse models, LC-MS RA quantification, adipogenesis assays, pharmacological rescue\",\n      \"pmids\": [\"29321172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific metabolic requirements not dissected with conditional models\", \"Downstream RAR target genes in adipose tissue not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"RDH10-derived RA acts specifically through RARα to initiate submandibular salivary gland formation, with Rdh10 and Aldh1a2 co-expressed in the initiating mesenchyme, demonstrating RAR isoform specificity downstream of RDH10.\",\n      \"evidence\": \"Rdh10 conditional loss-of-function, ex vivo SMG initiation assay, RAR isoform-specific agonists/antagonists\",\n      \"pmids\": [\"29986869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct RA target genes in salivary gland mesenchyme not identified\", \"Whether other RDHs partially compensate in this tissue is unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealing that Rdh10 loss causes mispatterned pharyngeal nerves and skeletal elements that physically block fetal mouth movement, leading to cleft palate, established a novel biomechanical mechanism downstream of RA signaling.\",\n      \"evidence\": \"Stage-specific Rdh10 inactivation, in utero ultrasound, X-ray microtomography, ex vivo culture\",\n      \"pmids\": [\"31300413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which RA target genes control pharyngeal nerve patterning is unknown\", \"Whether the biomechanical mechanism accounts for all RA-deficiency cleft palate cases is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic structure of RDH10, the full repertoire of direct RA-responsive target genes mediating its diverse developmental functions, the relative contribution of RDH10 versus other RDHs in adult tissues, and whether RDH10 mutations cause human Mendelian disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Systematic identification of direct downstream RA target genes across tissues is lacking\", \"Human genetic disease association through causative mutations not established in primary literature\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 4, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 5, 9, 10, 11]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RPE65\", \"CRALBP\", \"CRBP1\", \"ALDH1A2\", \"CRABP2\", \"LRAT\"],\n    \"other_free_text\": []\n  }\n}\n```"}